|
Volumn 39, Issue 3, 2000, Pages 167-183
|
Clinical pharmacokinetics of teicoplanin
|
Author keywords
[No Author keywords available]
|
Indexed keywords
ANTIINFECTIVE AGENT;
PROTEIN;
TEICOPLANIN;
ACCURACY;
ANTIMICROBIAL THERAPY;
ARTICLE;
CLINICAL TRIAL;
DOSE RESPONSE;
DRUG ABSORPTION;
DRUG BLOOD LEVEL;
DRUG CLEARANCE;
DRUG DETERMINATION;
DRUG DISTRIBUTION;
DRUG ELIMINATION;
DRUG HALF LIFE;
DRUG INDICATION;
DRUG INDUCED DISEASE;
DRUG METABOLISM;
DRUG PROTEIN BINDING;
DRUG STRUCTURE;
DRUG TOLERABILITY;
FLUORESCENCE POLARIZATION IMMUNOASSAY;
HUMAN;
PRIORITY JOURNAL;
RELIABILITY;
STEADY STATE;
|
EID: 0033800132
PISSN: 03125963
EISSN: None
Source Type: Journal
DOI: 10.2165/00003088-200039030-00001 Document Type: Article |
Times cited : (222)
|
References (3)
|